These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3474327)
1. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes. Nagler A; Rikilis I; Tatarsky I; Fabian I J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327 [TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Nagler A; Riklis I; Kletter Y; Tatarsky I; Fabian I Exp Hematol; 1986 Jan; 14(1):60-5. PubMed ID: 3510890 [TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Koeffler HP; Hirji K; Itri L Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438 [TBL] [Abstract][Full Text] [Related]
4. Differentiation of bone marrow cells from myelodysplastic patients in the presence of 1,25 dihydroxyvitamin D3 or 13-cis retinoic acid. Nagler A; Ricklis I; Gazit E; Tatarsky I; Fabian I Eur J Clin Invest; 1986 Aug; 16(4):297-301. PubMed ID: 3093242 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]]. Irino S; Taoka T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981 [TBL] [Abstract][Full Text] [Related]
6. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]. García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051 [TBL] [Abstract][Full Text] [Related]
7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3. Miyaura C; Abe E; Suda T; Kuroki T Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776 [TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 and the regulation of the differentiation and function of macrophages and granulocytes. Shezen E; Goldman R Int J Cell Cloning; 1985 Mar; 3(2):65-80. PubMed ID: 3839007 [TBL] [Abstract][Full Text] [Related]
9. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194 [TBL] [Abstract][Full Text] [Related]
10. In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives. Fabian I; Riklis I; Tatarsky I; Nagler A Cancer Res; 1986 May; 46(5):2596-9. PubMed ID: 3697999 [TBL] [Abstract][Full Text] [Related]
11. 1 alpha, 25-Dihydroxyvitamin D3 augments clonal growth of macrophages from rat bone marrow progenitor cells and modulates their function. Shezen E; Goldman R Int J Cell Cloning; 1986 Mar; 4(2):115-25. PubMed ID: 3754272 [TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-macrophages. Choudhuri U; Adams JA; Byrom N; McCarthy DM; Barrett J Haematologia (Budap); 1990; 23(1):9-19. PubMed ID: 2397925 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of human myeloid leukemia cell line ML-1 induced by retinoic acid and 1,25-dihydroxyvitamin D3. Haskovec C; Lemez P; Neuwirtová R; Wilhelm J; Jarolím P Neoplasma; 1990; 37(5):565-72. PubMed ID: 1700313 [TBL] [Abstract][Full Text] [Related]
14. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes. Swanson G; Picozzi V; Morgan R; Hecht F; Greenberg P Blood; 1986 Apr; 67(4):1154-61. PubMed ID: 3513868 [TBL] [Abstract][Full Text] [Related]
15. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders. Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461 [TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures. Dorshkind K; Reichel H; Norman AW Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458 [TBL] [Abstract][Full Text] [Related]
17. Effect of cytosine arabinoside on differentiation of normal human bone marrow cells. Nagler A; Kletter Y; Ricklis I; Gazit E; Tatarsky I; Fabian I Exp Hematol; 1986 Mar; 14(3):241-5. PubMed ID: 2419152 [TBL] [Abstract][Full Text] [Related]
18. The effect of low dose ARA-C on in-vitro haemopoiesis of marrow cells from myelodysplastic patients. Nagler A; Riklis I; Tatarsky I; Fabian I Leuk Res; 1987; 11(4):379-84. PubMed ID: 3561019 [TBL] [Abstract][Full Text] [Related]
19. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928 [TBL] [Abstract][Full Text] [Related]
20. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]